Boston Scientific’s latest deal is a good fit, analysts say

Boston Scientific Corp. ‘s latest deal, a takeover of privately held Millipede Inc., is a good strategic fit that will help the company build out its franchise of heart valve repair and replacement treatments, Needham analysts said Thursday.